Practical education for specialists and frontline practitioners treating CNS disorders
What Is BRAINWeek?
Developed by the PAINWeek organization, BRAINWeek officially launched in May 2021 as a live virtual conference. The 3-day agenda addressed the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners.
CE/CME Credit Hours
Topic Areas Covered
What Is BRAINWeekEnd?
To extend the reach of our CNS education, we are launching the BRAINWeekEnd Regional Conference series, beginning in October. These live, in-person events will speak to conditions such as dementia, epilepsy, migraine, multiple sclerosis, and stroke, all of which require a more inclusive approach to continuing medical education.
With the success of our inaugural live virtual meeting, we are pleased to announce even more opportunities to learn with BRAINWeek.
BRAINWeek at PAINWeek 2021
Want a sneak peek of the BRAINWeek curriculum? The PAINWeek 2021 National Conference is presenting a 2-day BRAINWeek track (Friday, 9/10 and Saturday, 9/11) featuring:
The L-Shaped Room: Challenges and Advances Managing Migraine
Who's on First? Neurologic and Psychiatric Management of Migraine
The Emerging Role of CGRP Inhibitors in the Prevention and Treatment of Migraine
Elevator to the Gallows: Trigeminal Autonomic Cephalalgias (TACs)
I Can't Hear You: The Association of Subclinical Hearing Loss with Cognitive Performance
Up the Down Staircase: Addressing Adherence in Relapsing Bipolar Disorder
Diagnosing on the Spectrum: Alzheimer's Disease and Lewy Body Dementia
Examining Cannabinoids in the Epilepsy Treatment Spectrum
Use code BRAINATPAIN to save $100 on registration
Featured BRAINWeek Courses
ROOM WITHOUT A VIEW:
MEETING THE INCREASED DEMAND FOR MENTAL HEALTH TREATMENT DURING COVID-19
The catastrophic health effects of the coronavirus pandemic are well established, as illustrated by the more than 32 million known cases and over 570,000 COVID-19-related deaths in the United States to date. What has also become more apparent is the immense psychological impact. As a result of the pandemic, much of society is experiencing increased stress in relation to numerous psychosocial factors. This session speaks to the need for increased mental health resources to cope with anxiety and fear about contracting the virus, increased social isolation, separation from family, job loss, economic uncertainty, and grieving the loss of a loved one to the disease.
This activity is supported by an educational grant from Allergan.
“The current estimated annual cost to American society of just nine of the most common neurological diseases is staggering, totaling $789 billion. These conditions include Alzheimer’s disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson’s disease.”
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action. Ann Neurol. 2017;81:479-484.